Jumbo S.A. (0LRI)
London Exchange · UK · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 14.90 |
|---|---|
| 52-week range | 14.90 – 28.52 |
| Return, 1 month / 3 months | −40.5% / +0.0% |
| Return, 1 year / 3 years | +8.6% / +43.8% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 47 |
| Volatility (1 year) | 182.8% |
| Worst drawdown (1 year) | -45.2% |
| Average daily value traded | 0.03M EUR |
| Dividend yield | 8.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Jumbo is a Greek retail chain based in Athens that runs stores selling toys, baby products, stationery, seasonal goods, party supplies and household items. Its shops serve families and general shoppers through a chain of outlets in Greece and several neighbouring countries, offering a broad range of low-priced goods for children and the home. The company also operates an online store alongside its physical shops, and its product mix shifts with the seasons to include festive and holiday merchandise.
The shares are listed on the London Exchange in UK under the code 0LRI, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Jumbo S.A. (0LRI) trades on the London Exchange in UK. It last closed at EUR 14.90 on 22 October 2026.
Its price-based Market X-Ray is 44 out of 100 (a weak price profile), ranking 2,400 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 8.6% and over the last three months it rose 0.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 50 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 0.5% | ||
| From 52-week high | -45.2% | ||
| Momentum | 70 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 0.0% | ||
| 6-month return | 4.9% | ||
| 12-month return, skipping the last month | 82.5% | ||
| Stability (higher is calmer) | 13 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 182.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -45.2% | ||
| Liquidity | 14 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.03M EUR | ||
| Zero-volume days | 36.7% | ||
| Income | 88 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 8.1% | ||
| Years with dividends | 6 |
Strengths
- Income: Dividend is high and has been paid regularly.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | −40.5% |
| 3 months | +0.0% |
| 6 months | +4.9% |
| 1 year | +8.6% |
| 3 years | +43.8% |
| 5 years | +75.9% |
Signals
| 50-day / 200-day average | 16.43 / 14.82 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 7.92 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 22 Jul 2026 | EUR 0.7000 |
| 23 Mar 2026 | EUR 0.5000 |
| 21 Jul 2025 | EUR 0.5063 |
| 24 Mar 2025 | EUR 0.4726 |
| 10 Jul 2024 | EUR 1.0000 |
| 19 Mar 2024 | EUR 0.6000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.